Form 4: Tenet Healthcare Director Trades THC Stock
Statement of Changes in Beneficial Ownership
J. Robert Kerrey, a Director at Tenet Healthcare Corp (THC), reported transactions involving common stock and restricted stock units.
Summary
- J. Robert Kerrey, a Director at Tenet Healthcare Corp (THC), reported the acquisition of 1,643 shares of common stock on May 22, 2026, through the settlement of restricted stock units.
- Additionally, Kerrey disposed of 607 shares of common stock on the same date for a price of $173.78 per share.
- Following these transactions, Kerrey beneficially owns 22,442 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports routine insider transactions involving stock acquisition and disposition without significant strategic implications.
Positives
- Director J. Robert Kerrey acquired 1,643 shares of common stock, indicating continued investment or compensation in the company.
- The settlement of restricted stock units suggests that performance or vesting conditions have been met.
Negatives
- Director J. Robert Kerrey disposed of 607 shares of common stock, which could be interpreted as a reduction in his direct holdings.
Future Outlook
No specific forward-looking statements or guidance were provided in this Form 4 filing.
Management Comments
- The reporting person settled 37% of his restricted stock units for cash and 63% for shares of THC common stock.
- Chad J. Wiener acted as Attorney-in-fact for J. Robert Kerrey.
Industry Context
StockSavvy.ai notes that insider transactions, such as those reported by Tenet Healthcare's director, are common in the healthcare services industry and can provide insights into management's confidence in the company's prospects.
Stakeholder Impact
- Shareholders may observe insider activity as an indicator of management's perspective on the company's valuation.
- Employees may view executive stock transactions as a reflection of company performance and future prospects.
Key Dates
| Date | Description |
|---|---|
| 05/22/2026 | Date of earliest transaction and transaction date for acquisition and disposition of common stock and settlement of restricted stock units. |
| 05/26/2026 | Date of signature on the filing. |
Keywords
Tenet Healthcare, THC, Form 4, Insider Trading, Director, Stock Transaction, Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.